Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.8750
+0.0272 (3.21%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $78.49 million as of September 18, 2025. Its market cap has decreased by -57.28% in one year.
Market Cap
78.49M
Enterprise Value
-4.86M
1-Year Change
-57.28%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $78.49M, an increase of 53.82%. That is a compound annual growth rate of 11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 76.05M | -19.26% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.06B |
| Johnson & Johnson | 429.74B |
| AbbVie | 383.31B |
| UnitedHealth Group | 317.24B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.46B |